Total Funding
84
60
Total FundingPost-IPO Equity raised
Growth Score
-12 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
15784
Nexalin Technology develops transcranial electrical stimulation equipment for the treatment of anxiety, insomnia, and depression.
- Michael Nketiah: Senior Vice President Regulatory, Clinical & Quality Affairs
- Mark White: CEO / President
About the Company
Nexalin Technology designs and manufactures transcranial electrical stimulation equipment to treat anxiety, insomnia, and depression. It engages in developing, building, and operating medical treatment facilities that utilize Nexalin technology, a non-invasive drugless therapy.
